Evidence map›Paper›PMID 25114630›Full record

ArticleNanoscale research letters2014

Synthesis of mixed-sequence oligonucleotides on mesoporous silicon: chemical strategies and material stability.

Monica Terracciano, Ilaria Rea, Luca De Stefano, Ivo Rendina, Giorgia Oliviero, Fabrizia Nici, Stefano D'Errico, Gennaro Piccialli, Nicola Borbone

Open access · goldAbstract read
In one paragraph

Article in Nanoscale research letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Monica TerraccianoInstitute for Microelectronics and Microsystems, National Council of Research, Naples 80131, Italy ; Department of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
Ilaria ReaInstitute for Microelectronics and Microsystems, National Council of Research, Naples 80131, Italy.
Luca De StefanoInstitute for Microelectronics and Microsystems, National Council of Research, Naples 80131, Italy.
Ivo RendinaInstitute for Microelectronics and Microsystems, National Council of Research, Naples 80131, Italy.
Giorgia OlivieroDepartment of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
Fabrizia NiciDepartment of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
Stefano D'ErricoDepartment of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
Gennaro PiccialliDepartment of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
Nicola BorboneDepartment of Pharmacy, University of Naples Federico II, Naples 80138, Italy.
University of Naples Federico II · ITInstitute for Microelectronics and Microsystems · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid screening tests in medical diagnostic and environmental analysis are often based on oligonucleotide biochips. In this paper, we studied the stability of functionalized mesoporous silicon supports in the solid-phase synthesis of oligonucleotides, exploiting several chemical procedures. A 19-mer mixed sequence has been successfully synthesized on aminosilane-modified porous silicon photonic structures. The process and the materials have been characterized by optical reflectivity, atomic force microscopy and high-performance liquid chromatography.

Indexed as

Deprotection conditionsDNA synthesisMesoporous silicon functionalizationSurface stability

Identifiers

PMID25114630
PMCPMC4079915
OpenAlexW2136186182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.